We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 121-140 of 10,000 results
  1. Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension

    Introduction

    In SERAPHIN, a long-term, event-driven, double-blind randomised controlled trial in pulmonary arterial hypertension (PAH), macitentan...

    Rogério Souza, Marion Delcroix, ... Richard N. Channick in Advances in Therapy
    Article Open access 12 July 2022
  2. High Tolerability, Favorable Safety, and Subjects' Preference for a Single 200 mg/2 mL Tildrakizumab Injection: A Phase I, Open-Label, Randomized Crossover Trial in Healthy Volunteers

    Introduction

    Tildrakizumab 200 mg/2 mL pre-filled syringe is a new preparation of tildrakizumab that is developed to facilitate patients’ compliance....

    Georgios Kokolakis, German Kreis, ... Wiebke Sondermann in Dermatology and Therapy
    Article Open access 19 August 2022
  3. Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan

    Introduction

    Nintedanib is recommended for the treatment of idiopathic pulmonary fibrosis (IPF); however, treatment discontinuation due to adverse...

    Takashi Ogura, Yoshikazu Inoue, ... Toshihiro Nukiwa in Advances in Therapy
    Article Open access 24 January 2023
  4. Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial

    Background

    In the INBUILD trial in patients with progressive fibrosing interstitial lung diseases (ILDs), nintedanib reduced the rate of decline in...

    Vincent Cottin, Fernando J. Martinez, ... Ulrich Costabel in Respiratory Research
    Article Open access 07 April 2022
  5. Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects

    Background and Objectives

    Ropanicant hydrochloride (previously known as SUVN-911, hereinafter referred to as ropanicant) is a novel alpha4 beta2...

    Ramakrishna Nirogi, Vijay Benade, ... Veera Raghava Chowdary Palacharla in Clinical Drug Investigation
    Article 13 August 2022
  6. Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial

    Aims/hypothesis

    Infection with coxsackie B viruses (CVBs) can cause diseases ranging from mild common cold-type symptoms to severe life-threatening...

    Heikki Hyöty, Susanna Kääriäinen, ... Miguel Sanjuan in Diabetologia
    Article Open access 19 February 2024
  7. Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy

    Background

    Antiseizure medication (ASM) as monotherapy or in combination is the treatment of choice for most patients with epilepsy. Therefore,...

    Laurent M. Willems, Milena van der Goten, ... Adam Strzelczyk in CNS Drugs
    Article Open access 04 June 2023
  8. Safety, tolerability of ES16001, a novel varicella zoster virus reactivation inhibitor, in healthy adults

    Purpose

    Herpes zoster (HZ), or shingles, is a clinical syndrome resulting from the reactivation of latent varicella zoster virus (VZV) within the...

    Jeon Hwang-Bo, Byungwook Kim, ... Se Chan Kang in European Journal of Medical Research
    Article Open access 12 August 2021
  9. A Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of 3 Weeks of Orally Administered Gefapixant in Healthy Younger and Older Adults

    Purpose

    Patients with chronic cough are typically female and have a mean age of ~ 60 years. However, initial pharmacokinetic (PK) characterization of...

    Jesse Nussbaum, Azher Hussain, ... Marian Iwamoto in Lung
    Article 07 June 2022
  10. Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies

    Introduction

    The transient receptor potential canonical (TRPC) ion channels have been implicated in the pathophysiology of major depressive disorder...

    René Fuertig, Markus Goettel, ... Vikas Sharma in CNS Drugs
    Article Open access 29 November 2023
  11. A Randomised Controlled Trial Comparing the Pharmacokinetics and Tolerability of the Proposed Adalimumab Biosimilar MSB11022 Delivered via Autoinjector and Pre-filled Syringe in Healthy Subjects

    Introduction

    The aim of the study was to demonstrate the bioequivalence, and compare the safety and tolerability of MSB11022, a proposed biosimilar of...

    Ahad Sabet, Daniel S. Dickerson, ... Joëlle Monnet in Rheumatology and Therapy
    Article Open access 09 March 2022
  12. A Phase 1 Single-Ascending-Dose Trial in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravenous PNT001, a Novel Mid-domain Tau Antibody Targeting cis-pT231 Tau

    Background

    PNT001 is a humanized full-length IgG4 S228P monoclonal antibody that binds the cis conformation of the phosphorylated Thr231-Pro232 motif...

    Wendy Luca, K. Foster, ... M. Jefson in The Journal of Prevention of Alzheimer's Disease
    Article Open access 24 January 2024
  13. PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice

    The PER a M panel pooled analys I s of effec T iveness and tolerability (PERMIT) study was a pooled analysis of data from 44 real-world studies from 17...

    Vicente Villanueva, Wendyl D’Souza, ... Eugen Trinka in Journal of Neurology
    Article Open access 24 August 2021
  14. Efficacy and tolerability of ketogenic diet therapy in 55 Chinese children with drug-resistant epilepsy in Northwest China

    Background

    Due to the tradition of carbohydrate-rich diet, challenges exist for ketogenic diet (KD) implementation in Northwest China. This study was...

    **angjun Dou, Zhi**g Wang, ... Dong Wang in Acta Epileptologica
    Article Open access 03 March 2022
  15. An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1

    Background

    The long-term efficacy and safety of the 2-drug regimen dolutegravir (DTG) + lamivudine (3TC) and 3-drug single-tablet regimens recommended...

    Lee A. Evitt, Sakina Nanji, ... Sonya J. Snedecor in AIDS Research and Therapy
    Article Open access 22 March 2023
  16. Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients

    Background

    After the reports of severe adverse reactions to the AstraZeneca ChAdOx1-S-nCoV-19 vaccine, patients who had received one dose of...

    Michael Haase, Paul Lesny, ... Fernando Macario in Journal of Nephrology
    Article Open access 27 January 2022
  17. Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study

    Background

    Erenumab is a monoclonal antibody (mAb) against the calcitonin gene related peptide (CGRP) receptor and is commonly used in migraine...

    Hannah Schenk, Dagny Holle, ... Armin Scheffler in The Journal of Headache and Pain
    Article Open access 11 May 2022
  18. Evaluation of Effectiveness and Tolerability of Fondaparinux in the Management of Symptomatic Acute Coronary Syndrome: A Real-World Evidence-Based Study on an Indian Population

    Introduction

    Fondaparinux is a low molecular weight heparin anticoagulant used to manage the full spectrum of acute coronary syndrome (ACS) patients...

    Jamshed Dalal, J. C. Mohan, ... Anand Subramaniyan in Cardiology and Therapy
    Article Open access 09 February 2022
  19. A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia

    Objective

    Clozapine is considered as the standard treatment for this subgroup, but the evidence is not unequivocal. There are several potential...

    Shimeng Dong, Johannes Schneider-Thoma, ... Stefan Leucht in European Archives of Psychiatry and Clinical Neuroscience
    Article Open access 01 August 2023
Did you find what you were looking for? Share feedback.